Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz T Weber

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Pediatric Nephrology (Berlin, Germany)|April 26, 2014
Therapeutic drug monitoring in pediatric renal transplantationLutz T Weber
Deutsches Arzteblatt International|September 4, 2023
Pharmacotherapy for Children and AdolescentsLutz T Weber
Pediatric Transplantation|November 2, 2017
Preexisting anti-HLA donor-specific antibodies in pediatric renal transplant recipients - A new challenge?Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|April 25, 2022
An update on lipid apheresis for familial hypercholesterolemiaChristina Taylan, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|July 12, 2018
Treatment strategies for children with steroid-dependent nephrotic syndrome: in need of controlled studiesUwe Querfeld, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|January 24, 2025
The Ca<sup>2+</sup>-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseasesAgnes Hackl, Lutz T Weber
Current Opinion in Pediatrics|February 7, 2022
IgA vasculitis nephritisEva Nüsken, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|August 5, 2022
"Don't let me be misunderstood": communication with patients from a different cultural backgroundChristina Taylan, Lutz T Weber
Frontiers in Pediatrics|March 30, 2018
Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic DiseaseSören Bäumner, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|March 4, 2017
Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effectsSören Bäumner, Lutz T Weber
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Pediatric Nephrology (Berlin, Germany)|April 26, 2014
Therapeutic drug monitoring in pediatric renal transplantationLutz T Weber
Deutsches Arzteblatt International|September 4, 2023
Pharmacotherapy for Children and AdolescentsLutz T Weber
Pediatric Transplantation|November 2, 2017
Preexisting anti-HLA donor-specific antibodies in pediatric renal transplant recipients - A new challenge?Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|April 25, 2022
An update on lipid apheresis for familial hypercholesterolemiaChristina Taylan, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|July 12, 2018
Treatment strategies for children with steroid-dependent nephrotic syndrome: in need of controlled studiesUwe Querfeld, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|January 24, 2025
The Ca<sup>2+</sup>-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseasesAgnes Hackl, Lutz T Weber
Current Opinion in Pediatrics|February 7, 2022
IgA vasculitis nephritisEva Nüsken, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|August 5, 2022
"Don't let me be misunderstood": communication with patients from a different cultural backgroundChristina Taylan, Lutz T Weber
Frontiers in Pediatrics|March 30, 2018
Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic DiseaseSören Bäumner, Lutz T Weber
Pediatric Nephrology (Berlin, Germany)|March 4, 2017
Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effectsSören Bäumner, Lutz T Weber
Pageof 15